Current Duke Appointments & Affiliations
Associate Professor of Medicine
·
2024 - Present
Medicine, Pulmonary, Allergy, and Critical Care Medicine,
Medicine
Member in the Duke Clinical Research Institute
·
2023 - Present
Duke Clinical Research Institute,
Institutes and Centers
Recent Scholarly Works
Timing of Bronchoscopy and Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Host Pneumonia.
Journal article Open Forum Infect Dis · June 2026 BACKGROUND: Immunocompromised patients are at high risk of pneumonia, with associated poor outcomes. Rapid microbiologic diagnosis is crucial, yet diagnostic yields vary widely. We evaluated the variability in diagnostic yield of usual care testing and pla ... Full text Link to item CiteEvaluation of the safety profile and intrapulmonary pharmacokinetics of intravenous fosfomycin in healthy adults.
Journal article Antimicrob Agents Chemother · February 13, 2025 UNLABELLED: This Phase 1 trial described the intrapulmonary pharmacokinetics and safety profile of IV fosfomycin in healthy participants. Fosfomycin, a broad-spectrum antibiotic mainly used to treat urinary tract infections, is being considered for treatme ... Full text Link to item CiteCost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia.
Journal article Pharmacoeconomics · September 2024 INTRODUCTION: Immunocompromised host pneumonia (ICHP) is an important cause of morbidity and mortality, yet usual care (UC) diagnostic tests often fail to identify an infectious etiology. A US-based, multicenter study (PICKUP) among ICHP patients with hema ... Full text Link to item CiteRecent Grants
IMPALA-2 A randomized, double-blind, placebo-controlled clinical trial of once-daily inhaled molgramostim nebulizer solution in adult subjects with autoimmune pulmonary alveolar proteinosis (aPAP) SAV006-05 Site 38
Clinical TrialPrincipal Investigator · Awarded by Savara Inc. · 2021 - 2026Pneumonia LOI
Clinical TrialPrincipal Investigator · Awarded by Karius, Inc. · 2019 - 2024Pneumonia in the Immunocompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens(Pickup)
Clinical TrialPrincipal Investigator · Awarded by Karius, Inc. · 2019 - 2023View All Grants
Education
University of Mississippi, School of Medicine ·
2009
M.D.